
The menopause aisle has a signal problem
If you have been told to try a supplement before considering hormone therapy, you are standing in one of the most crowded aisles in the wellness industry — wild yam creams, dong quai, evening primrose, $70 adaptogen blends, almost none of it backed by clinical evidence.
Start with what the experts say. The Menopause Society's 2023 review does not recommend any supplement or herbal remedy for hot flashes; the best nonhormonal options are prescription (SSRIs/SNRIs, gabapentin, fezolinetant) or cognitive behavioral therapy and clinical hypnosis, and hormone therapy remains the most effective treatment (NAMS, 2023). If you still want to try a supplement, here is what the trials show — symptom by symptom, at the doses they used — and it is modest.
Take the free supplement quiz →
Hot flashes and night sweats
Hot flashes affect most women during the menopausal transition. The supplement evidence here is limited and mixed — the most favourable pooled analysis found roughly a 20–25% reduction beyond placebo, newer ones found no effect on hot flashes, and all of it is well below what hormone therapy delivers.
Soy isoflavones bind weakly to estrogen receptors. A 2012 meta-analysis of 19 RCTs found they cut hot flash frequency by 20.6% and severity by 26.2%, with products over 18.8 mg of genistein per day more than twice as effective (Taku et al., 2012). But the effect is slow: a modelling analysis found soy isoflavones take about 13 weeks to reach even half their maximal effect and at least 48 weeks to reach 80% of it, with a maximum of about 25% beyond placebo (Li et al., Br J Clin Pharmacol, 2015). The evidence is mixed, though: a 2022 meta-analysis of 11 trials (Kang et al., 2022) and a 2025 meta-analysis of 12 trials (Luan et al., 2025) found no significant effect on hot flashes. If you still want to try soy isoflavones, research suggests 40–80 mg/day with more than 18.8 mg genistein. Give it at least 3 months and judge it honestly — any effect is modest and slow; whole-soy foods like tofu and edamame are an alternative. The Menopause Society does not recommend soy foods or extracts for hot flashes. Women with a history of estrogen-receptor-positive breast cancer should discuss concentrated soy extracts with their oncologist first.
ERr 731, a standardized Siberian rhubarb extract sold as Estrovera (one 4 mg tablet daily), produced significant reductions on the Menopause Rating Scale across four trials (390 women) in a 2024 meta-analysis (Dubey et al., 2024) — but the trials were few, heterogeneous and largely manufacturer-linked. The brand matters: generic rhubarb root is not the same extract.
Black cohosh is the most popular option and the most contested. The best systematic review (Cochrane, 16 trials, 2,027 women, median dose 40 mg/day) found black cohosh no better than placebo for hot flash frequency (Leach & Moore, 2012). If you try it anyway, stop after 8 weeks if nothing changes. Rare liver-injury reports mean you should avoid it if you have liver disease, skip alcohol while taking it, and stop if you develop yellowing skin, dark urine or abdominal pain.
- Skip for hot flashes: evening primrose oil, wild yam cream (it does not convert to progesterone in the body), dong quai, maca, and red clover — all null or near-null in controlled trials.
Sleep and mood
For ongoing insomnia, cognitive behavioral therapy for insomnia (CBT-I) is the recommended first treatment for adults (ACP guideline, 2016) — and CBT also helps hot flashes. Supplements are add-ons at most.
Melatonin rhythms flatten in menopausal women. A 2021 systematic review found supplementation improved subjective sleep quality in postmenopausal women with existing sleep problems, with doses of 3 mg and above also improving menopausal symptoms (Treister-Goltzman and Peleg, 2021). Trials in menopausal women used about 3 mg, and the wider sleep evidence comes from 1–5 mg taken 1–3 hours before bed; pooled trials of doses under 1 mg found no clear effect. Expect a small benefit — a few minutes faster to fall asleep — not a cure. Melatonin labels are often inaccurate — one analysis found actual content ranged from 83% below to 478% above the label (Erland & Saxena, 2017) — so pick a USP-verified 3 mg product.
Magnesium glycinate: a 2021 meta-analysis of three small, low-quality trials in older adults found magnesium shortened time to fall asleep by about 17 minutes, with no clear change in total sleep time (Mah and Pitre, 2021), and a 2017 systematic review found suggestive but poor-quality evidence that magnesium eases mild anxiety (Boyle et al., 2017). Research suggests 250 mg elemental magnesium (as glycinate) in the evening; don't exceed 350 mg/day from supplements, the NIH upper limit, and avoid it if you have kidney disease. For low mood, the proven options are talk therapy and, when needed, prescription antidepressants; supplement evidence for mood in menopause is limited, so talk to your clinician rather than self-treating moderate or severe symptoms.
Bone loss — the symptom you cannot feel
Bone loss speeds up in the years after menopause. Getting enough calcium and vitamin D matters for bone, but in a 2020 meta-analysis in postmenopausal women the bone-density gains came mostly from fortified dairy rather than pills (Liu et al., 2020), and the US Preventive Services Task Force does not recommend routine low-dose vitamin D and calcium supplements to prevent fractures in healthy postmenopausal women living at home (USPSTF, 2018). If you have osteopenia or osteoporosis, your clinician may prescribe them alongside proven bone drugs.
- Vitamin D3: research suggests most women need 600–800 IU/day (up to 1,000–2,000 IU is safe). The Endocrine Society advises against routine blood testing for most people; testing is mainly useful if you have osteoporosis or a condition that affects absorption (Endocrine Society, 2024).
- Calcium: research suggests about 1,200 mg/day total for women over 50, food first. Keep total intake under 2,000 mg/day (the upper limit), and prefer food sources — some studies link calcium pills, but not dietary calcium, to heart risk (NIH ODS).
- Vitamin K2: high-dose MK-4 (a prescription drug in Japan) modestly raised spine bone density without clearly preventing fractures (Su et al., 2019); evidence for over-the-counter MK-7 is limited. Do not take vitamin K if you use warfarin unless your prescriber agrees — it can change how well warfarin works (NIH ODS).

Match the supplement to the symptom
| Symptom | Supplement options (and the first-line alternative) | Evidence grade |
|---|---|---|
| Hot flashes / night sweats | Soy isoflavones, ERr 731; black cohosh no better than placebo (first-line: hormone therapy, or SSRIs/SNRIs, gabapentin, fezolinetant, CBT) | Limited (not recommended by The Menopause Society) |
| Sleep disturbance | Melatonin; magnesium glycinate (first-line: CBT-I) | Limited to Moderate (melatonin); Limited (magnesium) |
| Anxiety / low mood | Magnesium (first-line: therapy, antidepressants) | Limited |
| Bone loss | Food first; calcium + vitamin D3 if intake is low or you have osteoporosis; vitamin K2 | Moderate (calcium + D for low intake/osteoporosis); Limited (K2) |
| Vaginal dryness | None proven (vaginal moisturizers and low-dose vaginal estrogen are the proven options — ask your clinician) | Limited |
| Brain fog, weight gain | None with strong evidence | Insufficient |
The bottom line
Skip the marketing-heavy menopause complex blends. No supplement is recommended by The Menopause Society for hot flashes, and the effects seen in trials are modest, slow and inconsistent — the newest pooled analyses of soy found none for hot flashes. If your symptoms bother you, talk to your clinician about hormone therapy (MHT) if you have no contraindication, or a prescription nonhormonal option such as fezolinetant, an SSRI/SNRI or gabapentin — or CBT. If you still want to try a supplement, match one to your worst symptom, use the trial dose and form, and judge it honestly after about 3 months.
This article is educational, not medical advice. Supplements can interact with prescription medications and may not suit women with hormone-sensitive cancers, clotting disorders, kidney disease, or liver disease. Talk to a qualified clinician before starting anything new, especially if you use MHT, tamoxifen, SSRIs, or anticoagulants such as warfarin.